Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced the closing of a Series C funding round raising $105 ...
In the first study of its kind, researchers reported that fecal microbiota transplantation was a safe and beneficial approach for patients with type 1 diabetes and severe gastroenteropathy.